CASTEL SAN PIETRO, Switzerland, October 05, 2026 – Medacta Group SA ("Medacta" SIX:MOVE) today announces the appointment of Riccardo Fava as Group VP Investor Relations, Sustainability & Media Relations, effective October 1, 2026, reporting directly to CEO Francesco Siccardi.
In his new role, Riccardo will oversee Medacta's relationships with investors, analysts and the media, as well as the Group's sustainability strategy and reporting. Bringing these areas together under a single leadership is intended to give Medacta a consistent and coordinated voice towards the international financial community, the media and its wider stakeholders as the Group continues to grow.
Riccardo brings more than 20 years of experience across the medtech and financial sectors. From 2011 he served as Corporate Vice President, Communication, ESG & Investor Relations at Diasorin, where he led the company's engagement with the global investment community, its corporate communication and its sustainability agenda.
"Riccardo combines deep knowledge of the medtech industry with long-standing experience in capital markets and sustainability," said Francesco Siccardi, CEO of Medacta. "As we expand our global footprint, particularly in the United States, clear and consistent communication with investors and stakeholders is more important than ever. I am delighted to welcome him to our team."
Riccardo holds a degree in Economics summa cum laude from the University of Turin and is a qualified Chartered Accountant. He has further complemented his education with postgraduate and executive programs in artificial intelligence, project management, corporate communication and digital marketing.
CONTACT
Riccardo Fava
Group VP Investor Relations, Sustainability & Media Relations
ABOUT MEDACTA GROUP SA
Medacta Group SA (“Medacta”, SIX: MOVE) is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 70 countries. Follow us on Medacta.com, Medacta TV, YouTube, LinkedIn and X.
